Magnetic resonance spectroscopy in epilepsy: Clinical issues

Epilepsia

Volumn 43, Issue SUPPL. 1, 2002, Pages 32-39

  Cendes, Fernando ^a   Knowlton, Robert C ^b   Novotny, Edward ^c   Min, Li Li ^a   Antel, Samson ^d   Sawrie, Stephen ^b   Laxer, Kenneth D ^e   Arnold, Douglas ^d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Magnetic resonance spectroscopy; N acetyl aspartate; Temporal lobe epilepsy

Indexed keywords

ACETYLCYSTEINE;

BRAIN MAPPING; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

EID: 0036197196     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.043s1032.x     Document Type: Conference Paper

References (76)

1. 31P NMR using surface coils
2. MRS of the brain: Prospects for clinical application
3. Pratical aspects of clinical applications of MRS in the brain
4. Symbiosis between in vivo and in vitro NMR spectroscopy: The creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain
5. 31P MRS
6. 31P NMR spectroscopic imaging at 4.1 T
7. Phosphorus magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy
8. 1H NMR spectra of metabolites in the human brain
9. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
10. Immunohistochemical localization of N-acetylaspartate in rat brain
11. Reversible decreases in N-acetylaspartate after acute brain injury
12. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by H-1 magnetic resonance spectroscopic imaging
13. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: Evidence from proton MR spectroscopic imaging
14. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
15. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
16. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: Preliminary observations on tumor grading
17. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study
18. 13C magnetic resonance spectroscopy
19. 31P nuclear magnetic resonance spectroscopic studies of bicuculline-induced seizures in vivo
20. 1H nuclear magnetic resonance study
21. 1H magnetic resonance spectroscopic imaging
22. MRS metabolic markers of seizures and seizure-induced neuronal damage
23. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy
24. A proton magnetic resonance spectroscopy study of focal epilepsy in humans
25. Imaging of axonal damage in vivo in Rasmussen's syndrome
26. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images
27. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging
28. Magnetic resonance spectroscopy in temporal lobe epilepsy
29. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: A series of 100 patients
30. Proton magnetic resonance spectroscopic imgaging and MRI volumetric studies for lateralization of temporal lobe epilepsy
31. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures
32. 1H MRS in vivo
33. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy
34. Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging
35. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T
36. Proton MR spectroscopy in patients with seizure disorders
37. 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy
38. Lateralization of temporal lobe epilepsy (TLE) and discrimination of TLE from extra-TLE using pattern analysis of magnetic resonance spectroscopic and volumetric data
39. Neuronal metabolic dysfunction in patients with cortical developmental malformations: A proton magnetic resonance spectroscopic imaging study
40. Proton spectroscopic imaging at 4.1 Tesla in patients with malformations of cortical development and epilepsy
41. Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy
42. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy
43. Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy
44. Temporal lobe epilepsy: Bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging
45. Prognostic value of proton MR spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy
46. 1H MRSI for outcome in temporal lobectomy
47. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy
48. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy
49. 18F-fluorodeoxyglucose positron emission tomography
50. 1H-MRSI
51. Postictal stability of proton magnetic resonance spectroscopy imaging ((1)H-MRSI) ratios in temporal lobe epilepsy
52. Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy
53. 1H-MRSI-measured NAA/Cr
54. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus
55. 1H-MRS metabolic abnormalities in temporal lobe epilepsy
56. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy
57. Hippocampal structures: Anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging
58. 1H magnetic resonance spectroscopic imaging
59. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy
60. Function and organization in dysgenic cortex: Case report
61. Neuronal dysfunction in children with newly diagnosed temporal lobe epilepsy
62. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy
63. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T
64. Proton magnetic resonance spectroscopy: An emerging technology in pediatric neurology research
65. Cerebral GABA in pediatric epilepsy
66. GABA changes with vigabatrin in the developing human brain
67. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients
68. 31P spectroscopic imaging at 4.1 T
69. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy
70. 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy
71. 2 relaxometry
72. Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy
73. Nonlinear trends in hippocampal metabolic function and verbal memory: Evidence of cognitive reserve in temporal lobe epilepsy
74. 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo